|
J Biol Chem, Vol. 274, Issue 4, 2145-2156, January 22, 1999
Role of ERAB/L-3-Hydroxyacyl-coenzyme A Dehydrogenase
Type II Activity in A -induced Cytotoxicity
Shi
Du Yan,
Yigong
Shi§,
Aiping
Zhu,
Jin
Fu,
Huaijie
Zhu,
Yucui
Zhu,
Lenneen
Gibson,
Eric
Stern,
Kate
Collison¶,
Futwan
Al-Mohanna¶,
Satoshi
Ogawa ,
Alex
Roher**,
Steven G.
Clarke , and
David M.
Stern
From the Departments of Pathology, Physiology and Surgery, College
of Physicians and Surgeons of Columbia University, New York,
New York 10032, the ¶ King Faisal Specialist Hospital and
Research Centre, Riyadh, Saudi Arabia, the Department of Anatomy
and Neuroscience, Osaka University School of Medicine, Osaka, Japan,
the § Department of Molecular Biology, Princeton University,
Princeton, New Jersey 08544, the ** Haldeman Laboratory for
Alzheimer's Disease Research, Sun Health Research Institute, Sun City,
Arizona 85372, and the  Department of
Chemistry and Biochemistry, UCLA, Los Angeles, California 90024
Endoplasmic reticulum-associated amyloid
-peptide (A )-binding protein
(ERAB)/L-3-hydroxyacyl-CoA dehydrogenase type II
(HADH II) is expressed at high levels in Alzheimer's disease
(AD)-affected brain, binds A , and contributes to A -induced
cytotoxicity. Purified recombinant ERAB/HADH II catalyzed the
NADH-dependent reduction of S-acetoacetyl-CoA
with a Km of 68 µM and a
Vmax of 430 µmol/min/mg. The contribution
of ERAB/HADH II enzymatic activity to A -mediated cellular
dysfunction was studied by site-directed mutagenesis in the catalytic
domain (Y168G/K172G). Although COS cells cotransfected to overexpress
wild-type ERAB/HADH II and variant -amyloid precursor protein
( APP(V717G)) showed DNA fragmentation, cotransfection with
Y168G/K172G-altered ERAB and APP(V717G) was without effect. We thus
asked whether the enzyme might recognize alcohol substrates of which
the aldehyde products could be cytotoxic; ERAB/HADH II catalyzed
oxidation of a variety of simple alcohols (C2-C10) to their respective
aldehydes in the presence of NAD+ and
NAD-dependent oxidation of 17 -estradiol. Addition of
micromolar levels of synthetic A (1-40) to purified ERAB/HADH II
inhibited, in parallel, reduction of S-acetoacetyl-CoA
(Ki 1.6 µM), as well as oxidation
of 17 -estradiol (Ki 3.2 µM) and
( )-2-octanol (Ki 2.6 µM).
Because micromolar levels of A were required to inhibit ERAB/HADH II
activity, whereas A binding to ERAB/HADH II occurred at much lower
concentrations (Km 40-70 nM), the
latter more closely simulating A levels within cells, A
perturbation of ERAB/HADH II was likely to result from mechanisms other
than the direct modulation of enzymatic activity. Cells cotransfected
to overexpress ERAB/HADH II and APP(V717G) generated
malondialdehyde-protein and 4-hydroxynonenal-protein epitopes, which
were detectable only at the lowest levels in cells overexpressing
either ERAB/HADH II or APP(V717G) alone. Generation of such toxic
aldehydes was not observed in cells contransfected to overexpress
Y168G/K172G-altered ERAB and APP(V717G). We conclude that the
generalized alcohol dehydrogenase activity of ERAB/HADH II is central
to the cytotoxicity observed in an A -rich environment.
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y. Ren, H. W. Xu, F. Davey, M. Taylor, J. Aiton, P. Coote, F. Fang, J. Yao, D. Chen, J. X. Chen, et al.
Endophilin I Expression Is Increased in the Brains of Alzheimer Disease Patients
J. Biol. Chem.,
February 29, 2008;
283(9):
5685 - 5691.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. W. Lustbader, M. Cirilli, C. Lin, H. W. Xu, K. Takuma, N. Wang, C. Caspersen, X. Chen, S. Pollak, M. Chaney, et al.
ABAD Directly Links A{beta} to Mitochondrial Toxicity in Alzheimer's Disease
Science,
April 16, 2004;
304(5669):
448 - 452.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Zhang, R. McLaughlin, C. Goodyer, and A. LeBlanc
Selective cytotoxicity of intracellular amyloid {beta} peptide1-42 through p53 and Bax in cultured primary human neurons
J. Cell Biol.,
February 4, 2002;
156(3):
519 - 529.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Morishima, Y. Gotoh, J. Zieg, T. Barrett, H. Takano, R. Flavell, R. J. Davis, Y. Shirasaki, and M. E. Greenberg
{beta}-Amyloid Induces Neuronal Apoptosis Via a Mechanism that Involves the c-Jun N-Terminal Kinase Pathway and the Induction of Fas Ligand
J. Neurosci.,
October 1, 2001;
21(19):
7551 - 7560.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Greeve, I. Hermans-Borgmeyer, C. Brellinger, D. Kasper, T. Gomez-Isla, C. Behl, B. Levkau, and R. M. Nitsch
The Human DIMINUTO/DWARF1 Homolog Seladin-1 Confers Resistance to Alzheimer's Disease-Associated Neurodegeneration and Oxidative Stress
J. Neurosci.,
October 1, 2000;
20(19):
7345 - 7352.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. D. Yan, A. Roher, A. M. Schmidt, and D. M. Stern
Cellular Cofactors for Amyloid {beta}-Peptide-Induced Cell Stress : Moving from Cell Culture to in Vivo
Am. J. Pathol.,
November 1, 1999;
155(5):
1403 - 1411.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Du Yan, Y. Zhu, E. D. Stern, Y. C. Hwang, O. Hori, S. Ogawa, M. P. Frosch, E. S. Connolly Jr., R. McTaggert, D. J. Pinsky, et al.
Amyloid beta -Peptide-binding Alcohol Dehydrogenase Is a Component of the Cellular Response to Nutritional Stress
J. Biol. Chem.,
August 25, 2000;
275(35):
27100 - 27109.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Zhang, R. McLaughlin, C. Goodyer, and A. LeBlanc
Selective cytotoxicity of intracellular amyloid {beta} peptide1-42 through p53 and Bax in cultured primary human neurons
J. Cell Biol.,
February 4, 2002;
156(3):
519 - 529.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|